Pan Liu
Zhengzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Emerging Therapeutic Landscapes for KRAS-Mutant Pancreatic Ductal Adenocarcinoma: Beyond the "Undruggable" Paradigm.
Journal: The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology
Published: March 18, 2026
Emerging Therapeutic Landscapes for KRAS-Mutant Pancreatic Ductal Adenocarcinoma: Beyond the "Undruggable" Paradigm.
Journal: The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology
Published: February 02, 2026
Inhibition Effect of Pancreatic Exocrine Insufficiency on Immune Checkpoint Inhibitor Treatment in Pancreatic Cancer: A Retrospective Study.
Journal: ImmunoTargets and therapy
Published: September 27, 2023
The role of the hepatic autonomic nervous system.
Journal: Clinical and molecular hepatology
Published: July 10, 2023
A pan-cancer analysis of potassium channel tetramerization domain containing 12 in human cancer.
Journal: Scientific reports
Published: April 10, 2023
A six lipid metabolism related gene signature for predicting the prognosis of hepatocellular carcinoma.
Journal: Scientific reports
Published: November 01, 2022
Identifying cancer cell-secreted proteins that activate cancer-associated fibroblasts as prognostic factors for patients with pancreatic cancer.
Journal: Journal of cellular and molecular medicine
Published: May 05, 2022
LINC01419 Promotes the Proliferation of Hepatoma Cells by Recruiting XRCC5 and Regulating Its Phosphorylation to Repair DNA Damage.
Journal: Disease markers
Published: March 31, 2022
A Metastatic Intrahepatic Cholangiocarcinoma With HPCs Features: Report of a Case.
Journal: Frontiers in oncology
Published: December 05, 2021
Immortalization-upregulated protein promotes pancreatic cancer progression by regulating NPM1/FHL1-mediated cell-cycle-checkpoint protein activity.
Journal: Cell biology and toxicology
Published: November 15, 2021
miR-199a-5p inhibits the proliferation of hepatocellular carcinoma cells by regulating CDC25A to induce cell cycle arrest.
Journal: Biochemical and biophysical research communications
Published: July 05, 2021
Last Updated: 09/26/2026